Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colistin With or Without Ampisulbactam in Ventilator-Associated Pneumonia
IRCT20250109064326N1Phase 3Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Jan 2025
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of colistin and ampicillin + sulbactam in ventilator-associated pneumonia (VAP) (2 arms), sponsored by Shahid Sadoughi University of Medical Sciences. Started Jan 2025; status: completed.
02
Drugs
colistinampicillin + sulbactam
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on IRCT20250109064326N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250109064326N1.